Menopause and HRT: What Women Should Know About Hormone Replacement Therapy

Few topics in women's health have been as misunderstood as hormone replacement therapy (HRT) for menopause. For decades, it was prescribed routinely. Then a single study in 2002 created widespread fear. Now, more than 20 years later, the medical community has a much more nuanced understanding of who benefits, who doesn't, and what the real risks look like.

If you're going through menopause and wondering whether HRT is right for you, here's what the current evidence actually says.

What Happens During Menopause

Menopause — defined as 12 consecutive months without a menstrual period — marks the end of ovarian hormone production. The average age is 51, though the transition (perimenopause) can begin years earlier.

As estrogen and progesterone levels decline, many women experience:

• Hot flashes and night sweats — the most common reason women seek treatment. They range from mildly annoying to severely disruptive.
• Sleep disturbances — related to night sweats, hormonal shifts, and changes in sleep architecture
• Vaginal dryness and painful sex — caused by thinning and loss of elasticity in vaginal tissue (genitourinary syndrome of menopause)
• Mood changes — increased anxiety, irritability, or depression, particularly in women with a history of mood disorders
• Brain fog — difficulty concentrating and memory lapses
• Joint pain — surprisingly common and often not attributed to menopause
• Bone density loss — accelerated in the years immediately following menopause, increasing fracture risk

Not every woman experiences all of these symptoms, and severity varies enormously. Some women sail through menopause with minimal disruption. Others are miserable for years.

What Is HRT?

Hormone replacement therapy replaces the hormones your ovaries are no longer producing — primarily estrogen, and progesterone if you still have a uterus.

Estrogen is the primary hormone responsible for relieving menopausal symptoms. It's available as:

• Oral tablets (systemic)
• Transdermal patches (systemic — generally preferred for safety profile)
• Topical gels and sprays (systemic)
• Vaginal creams, rings, or tablets (local — primarily for vaginal symptoms)

Progesterone or progestin is added for women who have a uterus, because estrogen alone stimulates the uterine lining and increases the risk of endometrial cancer. The addition of progesterone prevents this. Women who have had a hysterectomy can take estrogen alone.

• Micronized progesterone (Prometrium) is generally preferred over synthetic progestins for its safety profile and tolerability
• Progesterone can be taken as a daily pill, cyclically, or delivered via an IUD

Bioidentical vs. synthetic — "bioidentical" means the hormones are chemically identical to what your body produces. FDA-approved bioidentical options include estradiol patches and micronized progesterone. These are not the same as compounded "bioidentical" hormones from specialty pharmacies, which lack the standardized testing and quality control of FDA-approved products.

The WHI Study: What Actually Happened

In 2002, the Women's Health Initiative (WHI) study was partially halted because women taking a specific combination — oral conjugated equine estrogen plus medroxyprogesterone acetate (Prempro) — showed a small increased risk of breast cancer, heart disease, stroke, and blood clots.

The media coverage was alarming. Millions of women stopped HRT overnight. Many suffered unnecessarily.

What got lost in the headlines:

• The study population was predominantly older women (average age 63) who started HRT many years after menopause — not the typical patient starting HRT for symptoms in her early 50s
• The absolute risk increases were small. For example, the breast cancer risk translated to roughly 8 additional cases per 10,000 women per year
• Women taking estrogen alone (those without a uterus) actually showed a decreased risk of breast cancer
• The specific formulation studied (oral conjugated equine estrogen + synthetic progestin) is not what most women are prescribed today
• Subsequent reanalysis showed that women who started HRT closer to menopause (within 10 years) had a significantly better risk profile than those who started later

What the Current Evidence Says

The medical consensus in 2026 is considerably more favorable toward HRT than the post-WHI panic suggested:

For women under 60 or within 10 years of menopause:

• HRT is the most effective treatment for hot flashes, night sweats, and vaginal symptoms
• The benefits generally outweigh the risks for symptomatic women without contraindications
• Transdermal estrogen (patches, gels) is preferred over oral estrogen because it doesn't increase clotting risk to the same degree
• Micronized progesterone appears safer than synthetic progestins regarding breast cancer risk

Bone health:

• HRT prevents the accelerated bone loss that occurs after menopause
• It reduces fracture risk and is a reasonable option for bone protection in women who are also treating symptoms

Cardiovascular considerations:

• Starting HRT near menopause appears to be cardiovascular-neutral or potentially beneficial
• Starting HRT after age 60 or more than 10 years past menopause carries more cardiovascular risk — this is the "timing hypothesis" that explains much of the WHI confusion

Breast cancer:

• Estrogen alone does not appear to increase breast cancer risk (and may decrease it slightly)
• Combined estrogen-progesterone therapy carries a small increased risk that appears after approximately 5 years of use
• The risk is roughly comparable to having two or more alcoholic drinks per day or being obese — context that rarely makes it into the headlines

Who Should Consider HRT

HRT is most appropriate for women who:

• Are experiencing moderate to severe menopausal symptoms that affect quality of life
• Are under 60 or within 10 years of menopause onset
• Don't have contraindications (history of breast cancer, active liver disease, unexplained vaginal bleeding, history of blood clots, or known clotting disorders)

It doesn't have to be a lifetime commitment. Many women use HRT for a defined period — through the worst of their symptoms — then taper off gradually. Others use it longer, particularly for bone protection or persistent genitourinary symptoms.

Who Should Not Take HRT

Clear contraindications include:

• Personal history of breast cancer
• History of blood clots or stroke
• Active liver disease
• Undiagnosed vaginal bleeding
• Known clotting disorders

Relative contraindications (where risks and benefits need careful weighing) include:

• Strong family history of breast cancer
• History of cardiovascular disease
• Migraine with aura (for oral estrogen specifically; transdermal may be safer)

Alternatives for Women Who Can't or Don't Want HRT

Not every woman wants or can take hormones. Other evidence-based options include:

• Low-dose vaginal estrogen — for vaginal symptoms only, this delivers minimal systemic absorption and is considered safe even for many women who can't take systemic HRT
• Fezolinetant (Veozah) — a newer non-hormonal medication FDA-approved specifically for hot flashes, working through a different mechanism (neurokinin receptor antagonism)
• SSRIs and SNRIs — certain antidepressants (particularly venlafaxine and paroxetine) reduce hot flash frequency and severity
• Gabapentin — can help with hot flashes and sleep
• Cognitive behavioral therapy — has evidence for managing hot flashes and sleep disruption
• Vaginal moisturizers and lubricants — for mild vaginal dryness

What doesn't have strong evidence: most supplements marketed for menopause, including black cohosh, soy isoflavones, and evening primrose oil. Some women report benefit, but clinical trials have been largely disappointing.

The Bigger Picture

Menopause is not a disease — it's a normal biological transition. But "normal" doesn't mean you have to suffer through it without help. The symptoms are real, they can be severe, and effective treatment exists.

The conversation around HRT has been clouded by fear for too long. The question shouldn't be "is HRT safe?" in the abstract. It should be: "Given my specific situation — my age, my symptoms, my health history, my risk factors — do the benefits outweigh the risks for me?"

That's a question best answered with a physician who will take the time to have that conversation honestly.

At Coral Clinic, we help women across Florida navigate menopause management through telehealth. Whether HRT is right for you or another approach makes more sense, we'll help you figure it out based on your individual situation — not based on headlines from 2002.